Akebia Therapeutics, Inc.盘中异动快速上涨5.19%报1.62美元

自选股智能写手04-10

北京时间2024年04月10日21时32分，Akebia Therapeutics, Inc.（AKBA.us）股票出现异动，股价快速拉升5.19%。截至发稿，该股报1.62美元/股，成交量86.2063万股，换手率0.41%，振幅2.65%。最近的财报数据显示，该股实现营业收入1.95亿美元，净利润-51.93百万美元，每股收益-0.28美元，毛利1.19亿美元，市盈率-5.73倍。机构评级方面...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2426497884?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-04-10 21:32","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2426497884","market":"us","top_or_hot":-1,"title":"Akebia Therapeutics, Inc.盘中异动 快速上涨5.19%报1.62美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年04月10日21时32分，Akebia Therapeutics, Inc.（AKBA.us）股票出现异动，股价快速拉升5.19%。截至发稿，该股报1.62美元/股，成交量86.2063万股，换手率0.41%，振幅2.65%。最近的财报数据显示，该股实现营业收入1.95亿美元，净利润-51.93百万美元，每股收益-0.28美元，毛利1.19亿美元，市盈率-5.73倍。机构评级方面...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410213211861e4a47&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Akebia Therapeutics, Inc.盘中异动 快速上涨5.19%报1.62美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAkebia Therapeutics, Inc.盘中异动 快速上涨5.19%报1.62美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-10 21:32 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410213211861e4a47&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年04月10日21时32分，Akebia Therapeutics, Inc.（AKBA.us）股票出现异动，股价快速拉升5.19%。截至发稿，该股报1.62美元/股，成交量86.2063万股，换手率0.41%，振幅2.65%。最近的财报数据显示，该股实现营业收入1.95亿美元，净利润-51.93百万美元，每股收益-0.28美元，毛利1.19亿美元，市盈率-5.73倍。机构评级方面...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410213211861e4a47&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AKBA","symbol_name":"Akebia Therapeutics, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410213211861e4a47&s=b","article_id":"2426497884","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410213211861e4a47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2426497884","pubTimestamp":1712755931,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年04月10日21时32分，Akebia Therapeutics, Inc.股票出现异动，股价快速拉升5.19%。截至发稿，该股报1.62美元/股，成交量86.2063万股，换手率0.41%，振幅2.65%。Akebia Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.25%。其相关个股中，Adial Pharmaceuticals, Inc、Tc Biopharm  Plc C/Wts 10/02/2028 、Jaguar Health, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Silo Pharma, Inc.、Abvc Biopharma, Inc.较为活跃，换手率分别为917.10%、62.55%、22.10%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、X4制药、Abvc Biopharma, Inc.，振幅分别为28.32%、13.39%、10.17%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc 是一家完全整合的生物制药公司。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"AKBA":"Akebia Therapeutics, Inc.","LENZ":"Therapeutics","BK4139":"生物科技"},"translate_title":"Akebia Therapeutics, Inc. quickly rose 5.19% to $1.62 in intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AKBA":1,"LENZ":1},"content_text":"北京时间2024年04月10日21时32分，Akebia Therapeutics, Inc.（AKBA.us）股票出现异动，股价快速拉升5.19%。截至发稿，该股报1.62美元/股，成交量86.2063万股，换手率0.41%，振幅2.65%。最近的财报数据显示，该股实现营业收入1.95亿美元，净利润-51.93百万美元，每股收益-0.28美元，毛利1.19亿美元，市盈率-5.73倍。机构评级方面，在所有3家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Akebia Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.25%。其相关个股中，Adial Pharmaceuticals, Inc、Tc Biopharm (Holdings) Plc C/Wts 10/02/2028 (To Pur Ads)、Jaguar Health, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Silo Pharma, Inc.、Abvc Biopharma, Inc.较为活跃，换手率分别为917.10%、62.55%、22.10%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、X4制药、Abvc Biopharma, Inc.，振幅分别为28.32%、13.39%、10.17%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc 是一家完全整合的生物制药公司。 该公司的经营部门从事为肾病患者开发和商业化新型疗法的业务。 公司目前的产品组合包括 1) Auryxia（柠檬酸铁），一种在美国批准上市的药物，用于控制透析依赖性慢性肾病成年患者的血清磷水平和治疗缺铁性贫血， 患有非透析依赖性慢性肾病的成年患者。 2) Vafseo (vadadustat)，一种口服缺氧诱导因子脯氨酰羟化酶抑制剂，在日本被批准用于治疗成人患者因慢性肾病引起的贫血。 3) HIF-PH 抑制剂处于临床前开发阶段。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2426497884"}

Akebia Therapeutics, Inc.盘中异动 快速上涨5.19%报1.62美元

精彩评论

Akebia Therapeutics, Inc.盘中异动快速上涨5.19%报1.62美元